Topics:

• Dear Pharma: There Is Nothing Centric About Patient-Centricity
  While the philosophy of patient centricity is noble, it has proven grossly ineffective for as long as it’s been a buzzword. Why? There is a fundamental disconnect at play that few, if any, perceive. It is one that patients and their respective patient advocacy organizations have never had the platform to share with industry until recently with social media as our bullhorn.
• Democratizing Cancer: How Freedom of Choice Improves Patient Reported Outcomes
  Historically, the decision-making tools allotted to cancer patients have been limited to medical teams (high-trust/low-resource) and the Internet (low-trust/high-resource). Social media has engendered an empowered generation of advocates and activists who have forced the hand of industry to adapt its approach in the form of “patient-centricity” – a meaningless term to the 23-year-old who just found out they have metastatic breast cancer while three months pregnant and finishing up her MBA. Learn how an ever-changing landscape of consumer activism is disrupting is ending isolation, building community, providing education, redefining quality-of-life, and improving health outcomes.
• Stop Innovating and Do Something: A Patient’s Take on Digital Transformation
  Tech-savvy healthcare consumers who use digital tools to self-advocate are the ones Pharma needs to look out for the most. Why? Because, with or without industry, they are already changing the landscape from the ground up. Big Pharma needs to adapt if they want to stay relevant by reimagining their fundamental philosophies about marketing communication and what success actually means.